Abstract
The bacterial species Neisseria meningitidis is a major cause of meningitis, with six meningococcal groups (serogroups) causing most cases. A licensed vaccine, MenACWY (Menveo), targets four of these meningococcal serogroups, and another vaccine, 4CMenB (Bexsero), targets serogroup B.
Funding Information
  • GlaxoSmithKline
  • GlaxoSmithKline
  • GlaxoSmithKline
  • GlaxoSmithKline
  • GlaxoSmithKline

This publication has 12 references indexed in Scilit: